Prescription Required
Formulation: ER Capsule
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: ER Capsule
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Norpace CR is a prescription medication used to treat certain serious, potentially life-threatening abnormal heart rhythms, also known as cardiac arrhythmias.
It contains disopyramide phosphate, an active ingredient that helps regulate electrical signals in the heart and control abnormal heartbeats.
Norpace CR belongs to a class of medications called Class IA antiarrhythmics. These medications work by blocking sodium channels in heart muscle cells, helping regulate the electrical activity responsible for maintaining a coordinated heartbeat.
The heart normally beats in a steady rhythm controlled by electrical impulses. When these signals become disrupted, the heart may beat too quickly, too slowly, or irregularly.
Certain abnormal heart rhythms can interfere with the heart’s ability to pump blood effectively and may lead to serious complications.
Norpace CR is specifically approved for treating documented ventricular arrhythmias, such as sustained ventricular tachycardia, that a healthcare provider considers life-threatening.
The medication is available as an extended-release capsule, which gradually releases disopyramide into the bloodstream.
Norpace CR helps control certain life-threatening ventricular arrhythmias, but it can also cause serious heart-related side effects. Treatment requires careful medical supervision and monitoring.Â
Norpace CR is used to treat certain serious ventricular arrhythmias.
Ventricular arrhythmias are abnormal heart rhythms that originate in the ventricles, the two lower chambers of the heart.
The ventricles are responsible for pumping blood from the heart to the lungs and the rest of the body.
Under normal conditions, electrical signals travel through the heart in an organized pattern, allowing the chambers to contract at the correct time.
When these electrical signals become abnormal, the ventricles may beat too rapidly or irregularly.
This can reduce the amount of blood pumped through the body and interfere with normal circulation.
Some patients may experience palpitations, dizziness, weakness, shortness of breath, or fainting.
In severe cases, ventricular arrhythmias may lead to cardiac arrest.
Norpace CR helps regulate abnormal electrical activity in the heart by blocking sodium channels involved in transmitting electrical impulses.
However, the medication is generally reserved for documented ventricular arrhythmias that are considered life-threatening.
It is not recommended for minor rhythm disturbances or occasional premature ventricular contractions that do not cause significant symptoms.
Norpace CR is used to manage serious ventricular arrhythmias when a healthcare provider determines that the potential benefits outweigh the risks of treatment.
Norpace CR is specifically indicated for certain patients with sustained ventricular tachycardia.
Ventricular tachycardia is a type of abnormal heart rhythm in which the ventricles beat much faster than normal.
When the heart beats too quickly, the chambers may not have enough time to fill with blood between contractions.
This can reduce blood flow to vital organs, including the brain.
Symptoms may include a racing heartbeat, chest discomfort, dizziness, shortness of breath, or fainting.
Sustained ventricular tachycardia is generally defined as an episode lasting more than 30 seconds or requiring earlier intervention because of circulatory instability.
This condition can be life-threatening, particularly in patients with underlying heart disease.
Norpace CR may help control abnormal ventricular electrical activity and reduce certain recurrent episodes.
However, treatment must be individualized because disopyramide can sometimes worsen existing arrhythmias or trigger new ones.
Initial treatment with antiarrhythmic medications for life-threatening ventricular arrhythmias is generally conducted in a hospital, where cardiac rhythm and other vital signs can be monitored.
Because Norpace CR is an extended-release formulation, it is not suitable when rapid establishment of medication levels is necessary.
Norpace CR may help control sustained ventricular tachycardia, but it is not an emergency treatment for an ongoing episode of unstable ventricular tachycardia.Â
Disopyramide has also been used in selected patients with supraventricular arrhythmias, although this is not an approved indication for Norpace CR under its U.S. prescribing information.
Supraventricular arrhythmias are abnormal heart rhythms that originate above the ventricles, usually in the atria or the atrioventricular region.
The atria are the two upper chambers of the heart that receive blood before it enters the ventricles.
Examples of supraventricular arrhythmias include atrial fibrillation and atrial flutter.
Atrial fibrillation occurs when the atria receive rapid, disorganized electrical signals, causing an irregular heartbeat.
Atrial flutter involves a more organized but abnormally rapid electrical rhythm in the atria.
These conditions may cause palpitations, fatigue, dizziness, shortness of breath, or reduced exercise tolerance.
In selected circumstances, a cardiologist may consider disopyramide for certain atrial arrhythmias when other treatment options are unsuitable.
This is considered off-label use, meaning the medication is prescribed for a condition outside its approved indication.
However, disopyramide is not generally a first-line treatment for atrial fibrillation or atrial flutter because of its potential to cause serious adverse effects.
Norpace CR is not specifically approved for supraventricular arrhythmias, including atrial fibrillation and atrial flutter. Its use for these conditions requires specialist assessment.
Norpace CR contains disopyramide, a Class IA antiarrhythmic medication that regulates electrical activity in the heart.
The heart relies on a coordinated electrical conduction system to maintain a regular heartbeat.
Electrical impulses normally begin in the sinoatrial node, often called the heart’s natural pacemaker.
These impulses travel through the atria, reach the atrioventricular node, and continue into the ventricles.
This process coordinates the contraction of the heart chambers.
When electrical impulses become abnormal, arrhythmias may develop.
Norpace CR works by changing how electrical signals travel through heart muscle cells.
Blocks Sodium Channels
Disopyramide blocks certain sodium channels in cardiac cells.
Sodium channels help initiate and transmit electrical impulses that trigger heart muscle contractions.
By slowing the movement of sodium into these cells, disopyramide reduces the speed at which certain electrical signals travel through the heart.
Prolongs the Electrical Recovery Period
Norpace CR also prolongs the duration of electrical activity and the refractory period in heart tissue.
The refractory period is the time during which heart cells cannot respond normally to another electrical impulse.
Extending this period may help interrupt certain abnormal electrical circuits responsible for arrhythmias.
Helps Stabilize Abnormal Heart Rhythms
By modifying electrical conduction and recovery, Norpace CR may help suppress certain dangerous ventricular arrhythmias.
However, these same effects can sometimes worsen abnormal heart rhythms.
For example, disopyramide may prolong the QT interval, an electrical measurement recorded on an electrocardiogram (ECG).
Excessive QT prolongation can increase the risk of a dangerous arrhythmia called torsades de pointes.
Norpace CR works by blocking sodium channels and changing electrical conduction in the heart, helping control certain serious arrhythmias while requiring careful ECG monitoring.Â
Norpace CR gradually releases disopyramide after oral administration.
The time needed to achieve its intended effects depends on the prescribed dosage, kidney function, other medications, and the patient’s medical condition.
Unlike immediate-release disopyramide, Norpace CR is designed to provide medication release over an extended period.
The extended-release formulation is generally taken at regular intervals to maintain therapeutic medication concentrations.
However, Norpace CR is not intended to provide rapid treatment for sudden, life-threatening arrhythmias.
Patients starting antiarrhythmic treatment for serious ventricular arrhythmias generally require hospital monitoring.
Your healthcare provider may use electrocardiograms, blood tests, and other assessments to determine whether the medication is effectively controlling the abnormal rhythm.
Continue taking Norpace CR according to your prescribed schedule, and never change your dosage without consulting your healthcare provider.
Norpace CR is available as extended-release capsules containing disopyramide phosphate.
The capsules should be swallowed whole and should not be crushed or chewed because doing so may interfere with the extended-release formulation.
The dosage depends on the type and severity of the arrhythmia, kidney and liver function, and response to treatment.
Possible side effects include dry mouth, constipation, blurred vision, difficulty urinating, dizziness, and nausea.
More serious complications include worsening arrhythmias, QT prolongation, low blood pressure, and heart failure.
Patients with certain pre-existing conduction abnormalities, congenital long QT syndrome, or cardiogenic shock should not take Norpace CR.
Your healthcare provider will assess your cardiovascular history and other medications before starting treatment.
Seek emergency medical attention if you experience fainting, severe dizziness, chest pain, difficulty breathing, or a rapid or irregular heartbeat accompanied by weakness or loss of consciousness.
Norpace CR should only be used under the supervision of a healthcare provider experienced in managing serious heart rhythm disorders.
Norpace CR is available as capsules that should be taken by mouth either with or without food, usually twice a day as directed. Take the medication exactly as prescribed, even if you feel fine. The extended-release capsules should be swallowed whole, and not crushed or chewed, to prevent the drug from being released all at once, which can cause side effects. The capsules can be taken with or without food, but some people find taking it with food or milk can help avoid stomach issues.
Dosages may vary depending on the individual and their medical condition and should be determined by a healthcare provider. The usual recommended adult dosage range for Norpace CR is between 400 to 800 mg per day, given in divided doses. However, the recommended dosage for most adults is 600 mg per day, taken in divided doses of 150 mg every 6 hours.
Use Norpace CR regularly to get the most benefit from it, so try to take the medication at the same time each day to help remember. Do not take Norpace CR to treat any heart rhythm disorder that has not been diagnosed by your doctor. If you are unsure about how to take your medication, speak to your healthcare provider or pharmacist.
Norpace CR (Disopyramide) is available in the following forms and strength:
Norpace CR is a prescription medication used to treat certain serious, potentially life-threatening abnormal heart rhythms, also known as cardiac arrhythmias.
It contains disopyramide phosphate, an active ingredient that helps regulate electrical signals in the heart and control abnormal heartbeats.
Norpace CR belongs to a class of medications called Class IA antiarrhythmics. Although it can help control certain dangerous heart rhythms, it may also cause serious side effects, particularly in patients with existing heart disease, kidney problems, or other medical conditions.
Possible complications include worsening arrhythmias, low blood pressure, heart failure, urinary retention, and changes in heart electrical conduction.
Patients taking Norpace CR require careful medical supervision, including electrocardiogram (ECG) monitoring and, when appropriate, blood tests.
Take Norpace CR exactly as prescribed. Do not change your dosage, stop treatment, or combine it with other medications without consulting your healthcare provider.
Norpace CR may cause new abnormal heart rhythms or worsen existing arrhythmias in some patients.
This is known as a proarrhythmic effect.
Although disopyramide is used to treat certain life-threatening ventricular arrhythmias, its effects on the heart’s electrical conduction system can occasionally trigger dangerous rhythm disturbances.
Norpace CR works by blocking sodium channels in heart muscle cells, slowing electrical conduction and prolonging the time needed for cells to recover between electrical impulses.
These effects may help suppress certain abnormal heartbeats. However, excessive changes in electrical conduction can also interfere with normal heart rhythm.
One important concern is prolongation of the QT interval, a measurement recorded on an electrocardiogram (ECG).
Excessive QT prolongation may lead to a serious ventricular arrhythmia called torsades de pointes.
Symptoms of a dangerous arrhythmia may include sudden palpitations, severe dizziness, weakness, fainting, or loss of consciousness.
Patients with existing heart disease, electrical conduction abnormalities, or electrolyte imbalances may be at greater risk.
Your healthcare provider may recommend regular ECGs and blood tests to monitor your heart rhythm and electrolyte levels.
Seek emergency medical attention if you experience fainting, severe dizziness, chest pain, or a rapid or irregular heartbeat accompanied by weakness or difficulty breathing.
Norpace CR should be used with particular caution in patients with heart failure or reduced heart pumping function.
Heart failure occurs when the heart cannot pump blood efficiently enough to meet the body’s needs.
Disopyramide has a negative inotropic effect, meaning it can reduce the force of heart muscle contractions.
In patients whose hearts already have difficulty pumping blood, this effect may worsen heart failure.
Symptoms may include increasing shortness of breath, swelling of the legs or ankles, sudden weight gain caused by fluid retention, and unusual fatigue.
Some patients may also experience difficulty breathing when lying flat or during physical activity.
Patients with significant heart failure may require an alternative antiarrhythmic medication or specialized treatment.
Your healthcare provider will evaluate your heart function before prescribing Norpace CR and may recommend additional cardiac monitoring.
Tell your healthcare provider if you have heart failure or reduced heart function. Seek urgent medical attention if you develop severe breathing difficulties, fainting, or rapidly worsening symptoms.
Norpace CR may cause a decrease in blood pressure, particularly in patients with existing cardiovascular problems.
Blood pressure is the force of blood pushing against the walls of the arteries as the heart circulates blood throughout the body.
When blood pressure becomes too low, important organs may not receive adequate blood flow.
Symptoms may include dizziness, lightheadedness, weakness, blurred vision, nausea, or fainting.
The risk may be greater in patients with reduced blood volume, dehydration, heart failure, or those taking other medications that lower blood pressure.
Older adults may also be more vulnerable to dizziness and falls associated with low blood pressure.
Your healthcare provider may recommend regular blood pressure monitoring during treatment.
If you experience lightheadedness when standing, rise slowly from sitting or lying positions.
Contact your healthcare provider if you experience persistent dizziness or low blood pressure. Seek emergency medical attention if you develop fainting, confusion, or severe weakness.
Norpace CR may cause anticholinergic side effects because disopyramide blocks certain effects of acetylcholine, a chemical messenger involved in many normal body functions.
Acetylcholine helps regulate saliva production, bowel movements, bladder emptying, and other involuntary activities.
When its effects are reduced, patients may experience dry mouth, constipation, blurred vision, or difficulty urinating.
Dry mouth is one of the more commonly reported side effects of disopyramide.
Persistent dry mouth may cause discomfort and increase the risk of dental problems.
Drinking water regularly, maintaining good oral hygiene, and using appropriate saliva substitutes may help relieve symptoms.
Some patients may also experience reduced sweating, which can make it more difficult to tolerate hot environments.
The severity of anticholinergic effects varies depending on the dosage and individual sensitivity.
Tell your healthcare provider if you develop persistent dry mouth, constipation, blurred vision, or difficulty urinating while taking Norpace CR. Do not increase or decrease your dosage without medical advice.
Norpace CR may cause urinary retention, a condition in which the bladder cannot empty completely.
This occurs because disopyramide has anticholinergic effects that can interfere with normal bladder muscle activity.
Patients with an enlarged prostate, urinary obstruction, or certain bladder disorders may be particularly susceptible.
Symptoms may include difficulty starting urination, a weak urine stream, frequent urination in small amounts, or a feeling that the bladder has not emptied.
In severe cases, a person may become completely unable to urinate.
Urinary retention can cause significant discomfort and may require urgent treatment.
Norpace CR may be unsuitable for patients with existing urinary retention unless a specialist determines that treatment can be managed safely.
Tell your healthcare provider if you have prostate enlargement or bladder problems. Seek urgent medical attention if you become unable to urinate, especially if you experience severe lower abdominal pain.
Norpace CR may cause blurred vision because of its anticholinergic effects.
These effects can interfere with the eye’s ability to focus normally, particularly when looking at nearby objects.
Some patients may experience temporary visual disturbances, difficulty reading, or sensitivity to bright light.
Patients with certain forms of glaucoma may be at greater risk of complications.
In particular, disopyramide may increase the risk of an acute angle-closure glaucoma attack in susceptible individuals.
An acute angle-closure glaucoma attack is a medical emergency that may cause severe eye pain, blurred vision, headache, nausea, or halos around lights.
Tell your healthcare provider if you have glaucoma or other significant eye problems before taking Norpace CR.
Seek emergency medical attention if you experience sudden eye pain, severe blurred vision, or halos around lights.
Norpace CR may interact with certain prescription medications, over-the-counter products, vitamins, and herbal supplements.
Some interactions can increase disopyramide concentrations in the bloodstream, while others may interfere with the medication’s ability to control abnormal heart rhythms.
Combining Norpace CR with other medications that affect the heart’s electrical conduction system may increase the risk of dangerous arrhythmias.
For example, certain antiarrhythmic medications may cause excessive widening of the QRS complex or prolongation of the QT interval on an electrocardiogram (ECG).
These changes may increase the risk of serious cardiac complications.
Certain antibiotics, including clarithromycin and erythromycin, can interfere with the breakdown of disopyramide and potentially cause life-threatening interactions.
Other medications, such as certain antifungal drugs and medicines that affect the CYP3A4 enzyme, may also increase disopyramide exposure.
Medications with anticholinergic effects, including some antihistamines and bladder medications, may worsen dry mouth, constipation, blurred vision, or urinary retention.
Your healthcare provider or pharmacist should review your complete medication list before treatment begins.
Tell your healthcare provider about all medications and supplements you take. Do not start a new medication or discontinue an existing treatment without discussing potential interactions.Â
Consult your healthcare provider before taking Norpace CR if you are pregnant, planning to become pregnant, or think you may be pregnant.
There is limited information about the safety of disopyramide during human pregnancy.
Animal studies have identified potential reproductive effects, but the available evidence does not fully establish the risks to a developing baby.
Disopyramide can cross the placenta, and its use during pregnancy requires careful consideration.
However, serious maternal arrhythmias can also pose significant risks during pregnancy.
Uncontrolled abnormal heart rhythms may interfere with blood circulation and affect the health of both the mother and developing baby.
For this reason, your healthcare provider will consider the severity of your heart condition, the benefits of treatment, and the potential risks.
Alternative medications may be recommended when appropriate.
Do not start or stop Norpace CR during pregnancy without specialist medical guidance. If you become pregnant during treatment, contact your healthcare provider promptly to review your treatment plan.
Norpace CR may cause dizziness, lightheadedness, or fainting in some patients.
These symptoms may occur because the medication affects blood pressure, heart function, or electrical conduction within the heart.
Some patients may feel unsteady when standing up or changing positions.
Others may experience weakness, fatigue, or reduced alertness.
Dizziness can increase the risk of falls, especially in older adults and patients with existing balance problems.
Avoid driving, operating heavy machinery, or performing potentially dangerous activities until you know how Norpace CR affects you.
If you experience mild dizziness, sit or lie down until the sensation passes.
However, fainting or severe dizziness may indicate a serious heart rhythm disturbance or dangerously low blood pressure.
Avoid driving or operating machinery if Norpace CR causes dizziness or reduced alertness. Seek emergency medical attention if you faint or develop severe dizziness, especially with palpitations, chest pain, or difficulty breathing.
Norpace CR may cause digestive side effects, including nausea, vomiting, stomach discomfort, and reduced appetite.
These symptoms may be more noticeable when treatment begins or after the dosage is adjusted.
Some patients may experience mild nausea that improves as the body adjusts to the medication.
Taking Norpace CR with food may help reduce stomach discomfort for certain patients.
However, follow your healthcare provider’s instructions regarding medication administration.
Norpace CR is an extended-release formulation. The capsules should be swallowed whole and must not be crushed or chewed.
Persistent vomiting may interfere with medication absorption and contribute to dehydration.
Dehydration and electrolyte imbalances can be particularly concerning in patients with abnormal heart rhythms.
Low or high potassium levels may also increase the risk of serious cardiac complications during disopyramide treatment.
Contact your healthcare provider if you experience persistent nausea, vomiting, or loss of appetite. Seek prompt medical attention if vomiting is severe or accompanied by weakness, dizziness, or heart rhythm changes.
Norpace CR should be used with caution in patients with liver disease or reduced liver function.
The liver helps process disopyramide and other medications.
When liver function is impaired, disopyramide may remain in the body longer than expected.
This can increase medication exposure and the risk of side effects.
Patients with liver impairment may require a lower dosage and additional monitoring.
Norpace CR has also been associated with occasional increases in liver enzyme levels.
Liver enzymes are substances measured through blood tests to help evaluate liver health.
Elevated levels may indicate liver irritation or injury, although they do not always mean that serious liver damage has occurred.
Rare cases of cholestatic jaundice, a condition involving impaired bile flow and yellowing of the skin or eyes, have also been reported.
Your healthcare provider may recommend liver function testing when clinically appropriate, especially if you have an existing liver condition or develop symptoms suggesting liver injury.
Warning signs may include persistent nausea, unusual fatigue, dark urine, pale stools, abdominal pain, or yellowing of the skin or eyes.
Tell your healthcare provider if you have liver disease before taking Norpace CR. Seek prompt medical assessment if you develop jaundice, dark urine, or other symptoms of possible liver injury.Â
Patients with kidney disease should inform their healthcare provider before starting Norpace CR.
The kidneys play an important role in eliminating disopyramide from the body.
More than half of the medication may be eliminated through urine without being significantly changed.
When kidney function is reduced, disopyramide can accumulate in the bloodstream.
This may increase the risk of low blood pressure, abnormal heart rhythms, excessive anticholinergic effects, and other serious complications.
Patients with impaired kidney function may require a lower dosage.
Importantly, Norpace CR is not recommended for patients with severe kidney impairment, defined in its U.S. prescribing information as a creatinine clearance of 40 mL/min or less.
In these patients, a healthcare provider may consider a different formulation or alternative treatment.
Your healthcare provider may recommend blood tests to assess kidney function and ECG monitoring to identify changes in heart electrical conduction.
Tell your healthcare provider if you have kidney disease or reduced kidney function. Never adjust your Norpace CR dosage without medical guidance.Â
Do not stop taking Norpace CR without consulting your healthcare provider.
Norpace CR is prescribed to control certain serious, potentially life-threatening ventricular arrhythmias.
Stopping treatment may allow abnormal heart rhythms to return.
In patients with serious ventricular arrhythmias, recurrence of the underlying rhythm disturbance can be dangerous.
However, seizures are not an established or typical withdrawal effect of stopping disopyramide.
The primary concern is the possible return or worsening of the heart rhythm disorder being treated.
Your healthcare provider will determine whether treatment can be safely discontinued and whether an alternative antiarrhythmic medication or procedure is necessary.
Do not reduce the dose, skip medication intentionally, or change your dosing schedule without medical advice.
If you need to stop Norpace CR because of side effects, contact your healthcare provider promptly.
Do not discontinue Norpace CR on your own. Seek emergency medical attention if you develop fainting, severe palpitations, chest pain, or difficulty breathing.
Norpace CR is used to treat certain serious ventricular arrhythmias and requires careful medical supervision.
Although it may help control abnormal heart rhythms, it can also cause dangerous changes in electrical conduction, low blood pressure, and worsening heart failure.
Patients with kidney or liver disease may require dosage adjustments or alternative treatment.
Anticholinergic side effects such as dry mouth, constipation, blurred vision, and urinary retention are also possible.
Regular ECG monitoring and appropriate blood tests help healthcare providers assess treatment safety and effectiveness.
Take Norpace CR exactly as prescribed and report new or worsening symptoms promptly. Never stop or change the medication without medical guidance.
These precautions are not an exhaustive list of all possible side effects, contraindications, or drug interactions. Your healthcare provider should review your medical history and all current medications before and during treatment.
Norpace CR should only be used during pregnancy when a healthcare provider determines that the potential benefits to the mother outweigh the possible risks to the developing baby. Norpace CR contains disopyramide phosphate, a Class IA antiarrhythmic medication used to treat certain serious, potentially life-threatening abnormal heart rhythms. There is limited information about the safety of disopyramide during human pregnancy. Although animal studies have identified potential reproductive effects, these findings do not fully establish the risks to a developing baby. Disopyramide can cross the placenta, meaning the medication may reach the developing baby through the mother’s bloodstream. However, untreated serious heart rhythm disorders can also pose significant risks during pregnancy. Abnormal heart rhythms may interfere with blood circulation and, in severe cases, affect the health of both the mother and baby. Your healthcare provider will consider the severity of your heart condition, your medical history, and the potential benefits and risks of treatment before recommending Norpace CR. If treatment is necessary, your healthcare provider may recommend additional monitoring, including electrocardiograms (ECGs), blood tests, and assessments of the baby’s health. Alternative medications may be considered depending on the type of arrhythmia and the stage of pregnancy. Do not start, stop, or change your Norpace CR dosage during pregnancy without consulting your healthcare provider. If you become pregnant while taking the medication, contact your healthcare provider promptly to review your treatment plan.
Norpace CR should be stored at controlled room temperature, generally between 20°C and 25°C (68°F and 77°F), according to the manufacturer’s instructions. Keep the medication in its original container, tightly closed, and protected from excessive heat, moisture, and direct sunlight. Avoid storing Norpace CR in bathrooms, near kitchen sinks, or in areas where temperature and humidity frequently change. High humidity and excessive heat may affect the stability and quality of certain medications. Do not store Norpace CR in a refrigerator or freezer unless the product packaging specifically instructs you to do so. Keep the capsules out of the sight and reach of children and pets to prevent accidental ingestion. Norpace CR is a medication that affects the heart’s electrical activity. Accidental ingestion, particularly by children, can cause serious and potentially life-threatening complications. Always check the expiration date before taking the medication. Do not use capsules that have expired or appear damaged. If you have unused or expired Norpace CR capsules, ask your pharmacist about the safest way to dispose of them. Do not flush the medication down the toilet or pour it into household drains. Store Norpace CR at room temperature in a secure, dry location, and keep it away from children and pets. Follow the storage instructions printed on your medication packaging.
If you forget to take a dose of Norpace CR, take it as soon as you remember, unless it is almost time for your next scheduled dose. If your next dose is approaching, skip the missed dose and continue with your regular dosing schedule. Do not take two doses together to make up for a missed capsule. Taking additional disopyramide may increase the risk of serious side effects, including low blood pressure, dizziness, and dangerous changes in heart rhythm. Norpace CR is an extended-release medication designed to maintain disopyramide levels in the bloodstream over an extended period. Taking the medication consistently is important because missed doses may reduce protection against the serious ventricular arrhythmias being treated. However, doubling a dose can cause excessive medication exposure and potentially dangerous cardiac complications. If you frequently forget your medication, consider using a medication reminder, phone alarm, or pill organizer. If you miss several consecutive doses or are uncertain about when to take your next capsule, contact your healthcare provider or pharmacist for instructions. Do not independently change your treatment schedule or take extra medication because you experience palpitations. Never double your Norpace CR dose to make up for a missed dose. Contact your healthcare provider if you miss multiple doses or develop new or worsening heart rhythm symptoms.
Norpace CR begins affecting the heart’s electrical activity as disopyramide is absorbed into the bloodstream. Because Norpace CR is an extended-release formulation, the medication is released gradually rather than all at once. Blood concentrations generally begin increasing within the first several hours after taking a dose. The time needed to achieve stable medication levels depends on factors such as kidney function, liver function, dosage, and individual response. For patients with normal kidney function, relatively stable blood concentrations may be reached within approximately two to three days of regular dosing. However, this may take longer in patients with reduced kidney function. Unlike medications used for chronic conditions that require several weeks before producing noticeable effects, Norpace CR can begin influencing cardiac electrical activity after the first doses. Nevertheless, determining whether the medication is effectively controlling a serious arrhythmia may require additional monitoring. Your healthcare provider may use electrocardiograms (ECGs), heart rhythm monitoring, and blood tests to evaluate treatment effectiveness. The prescribed dosage may also need adjustment based on your response, kidney function, and any side effects. Because Norpace CR can sometimes cause new arrhythmias or worsen existing ones, treatment for life-threatening ventricular arrhythmias is generally initiated in a hospital or another closely monitored medical setting. Do not increase your dosage if you do not notice an immediate improvement. Norpace CR begins working as it is absorbed, but the time needed to establish stable medication levels and assess treatment effectiveness varies. Regular cardiac monitoring is essential, and dosage adjustments should only be made by your healthcare provider.
| Generic name: | Disopyramide |
|---|---|
| Formulation: | ER Capsule |
| Strength(s): | 100mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Norpace CR (disopyramide) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Norpace CR is available in 100 mg extended-release tablets and is commonly prescribed in dosages up to 800 mg per day, typically taken twice daily. For a 90-day supply, this means you would order up to 720 tablets (90 days x 8 tablets per day if taking the maximum dose of 800 mg per day).
No, we do not sell disopyramide on our website. However, you can still enjoy low prices on Norpace CR, which contains disopyramide as an active ingredient. To purchase Norpace CR, you will need a valid prescription from your healthcare provider. We require this to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it securely through your online account.
Yes, we ship Norpace CR (disopyramide) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Norpace CR (Disopyramide). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Norpace CR (Disopyramide).
REVIEWS